| Literature DB >> 28050233 |
Wânia Rezende Lima1,2, Giulliana Tessarin-Almeida1, Andrei Rozanski3, Kleber S Parreira4, Miriam S Moraes1, David C Martins5, Ronaldo F Hashimoto6, Pedro A F Galante3, Célia R S Garcia1.
Abstract
According to the World Health Organization (WHO), Plasmodium falciparum is the deadliest parasite among all species. This parasite possesses the ability to sense molecules, including melatonin (MEL) and cAMP, and modulate its cell cycle accordingly. MEL synchronizes the development of this malaria parasite by activating several cascades, including the generation of the second messenger cAMP. Therefore, we performed RNA sequencing (RNA-Seq) analysis in P. falciparum erythrocytic stages (ring, trophozoite and schizont) treated with MEL and cAMP. To investigate the expression profile of P. falciparum genes regulated by MEL and cAMP, we performed RNA-Seq analysis in three P. falciparum strains (control, 3D7; protein kinase 7 knockout, PfPK7-; and PfPK7 complement, PfPK7C). In the 3D7 strain, 38 genes were differentially expressed upon MEL treatment; however, none of the genes in the trophozoite (T) stage PfPK7- knockout parasites were differentially expressed upon MEL treatment for 5 hours compared to untreated controls, suggesting that PfPK7 may be involved in the signaling leading to differential gene expression. Moreover, we found that MEL modified the mRNA expression of genes encoding membrane proteins, zinc ion-binding proteins and nucleic acid-binding proteins, which might influence numerous functions in the parasite. The RNA-Seq data following treatment with cAMP show that this molecule modulates different genes throughout the intraerythrocytic cycle, namely, 75, 101 and 141 genes, respectively, in the ring (R), T and schizont (S) stages. Our results highlight P. falciparum's perception of the external milieu through the signaling molecules MEL and cAMP, which are able to drive to changes in gene expression in the parasite.Entities:
Keywords: P. falciparum; cAMP; malaria; melatonin; transcripts; ubiquitin proteasome
Year: 2016 PMID: 28050233 PMCID: PMC5115173 DOI: 10.18632/genesandcancer.118
Source DB: PubMed Journal: Genes Cancer ISSN: 1947-6019
Figure 1Differentially expressed genes detected in the trophozoite stage of the P. falciparum 3D7 strain treated with melatonin for 5 hours
Heat map of 38 differentially expressed genes affected by melatonin treatment. Gene expression in the trophozoite stage P. falciparum 3D7 parasites treated with 100 nM melatonin for 5 hours was compared with that of the same stage P. falciparum 3D7 parasites treated with ethanol as a control. R1 and R2 are duplicates.
Figure 2Pie chart showing the distribution of GO categories for the 38 differentially expressed genes in the 3D7 strain after 5 hours of incubation with 100 nM melatonin
Figure 3Differentially expressed genes detected in the trophozoite stage of the P. falciparum 3D7 strain treated with cAMP for 6 hours
Heat map of 38 differentially expressed genes affected by exposing trophozoite stage P. falciparum 3D7 parasites to 20 μM 6-Bnz-cAMP analog compared to the non-treated 3D7 trophozoite parasites. Only those genes that had a fold change in expression > 2 are displayed.
Pathways enriched in P. falciparum treated with cAMP as identified by functional annotation cluster analysis using a chart from the DAVID Bioinformatics database
| Ring stage | |||
|---|---|---|---|
| Annotation cluster | Enrichment score: 1.16 | Count | p-value |
| SP_PIR_KEYWORDS | ribosomal protein | 7 | 0.0048 |
| GOTERM_MF_FAT | structural constituent of ribosome | 7 | 0.011 |
| GOTERM_BP_FAT | translation | 9 | 0.011 |
| KEGG_PATHWAY | ribosome | 6 | 0.012 |
| GOTERM_MF_FAT | structural molecule activity | 7 | 0.026 |
| GOTERM_CC_FAT | ribosome | 7 | 0.047 |
| Annotation cluster | Enrichment score: 0.38 | ||
| GOTERM_CC_FAT | Golgi apparatus | 3 | 0.042 |
| KEGG_PATHWAY | ubiquinone and other terpenoid-quinone biosynthesis | 2 | 0.042 |
| GOTERM_BP_FAT | quinone cofactor metabolic process | 2 | 0.046 |
| Annotation cluster 1 | Enrichment score: 1.32 | ||
| SP_PIR_KEYWORDS | isomerase | 5 | 0.0094 |
| SP_PIR_KEYWORDS | rotamase | 3 | 0.031 |
| INTERPRO | peptidyl-prolyl cis-trans isomerase, cyclophilin-type | 3 | 0.031 |
| GOTERM_MF_FAT | peptidyl-prolyl cis-trans isomerase activity | 3 | 0.047 |
| GOTERM_MF_FAT | cis-trans isomerase activity | 3 | 0.047 |
| Annotation cluster 2 | Enrichment score: 1.17 | ||
| GOTERM_BP_FAT | coenzyme metabolic process | 5 | 0.025 |
| GOTERM_MF_FAT | acid-amino acid ligase activity | 4 | 0.026 |
Figure 4Differentially expressed genes detected in the ring stage of the P. falciparum 3D7 strain treated with cAMP for 6 hours
Heat map of 32 differentially expressed genes affected by treating ring stage P. falciparum 3D7 parasites with 20 μM 6-Bnz-cAMP compound compared to non-treated 3D7 ring parasites. Only those genes that had a fold change in expression > 2 are displayed.
Figure 5Differentially expressed genes detected in the schizont stage of P. falciparum 3D7 strain treated with cAMP for 6 hours
Heat map of 64 differentially expressed genes affected by exposing schizont stage P. falciparum 3D7 parasites to 20 μM 6-Bnz- cAMP compound compared to non-treated 3D7 schizont parasites. Only those genes that had a fold change in expression > 2 are displayed.
Enriched pathways of P. falciparum treated with cAMP and melatonin
| Ring (cAMP) | ||||
|---|---|---|---|---|
| Gene ID | Gene | Gene Description | Pathway | Fold Change |
| 2277.t00118, MAL12P1.117, PFL0585w | polyubiquitin (PfpUB) | UPS | 5 | |
| MAL8P1.23 | E3 ubiquitin-protein ligase, putative | UPS | 0.2 | |
| PF10_0232 | chromodomain-helicase-DNA-binding protein 1 homolog, putative (CHD1) | Pyrimidine metabolism | 0.5 | |
| PFL1725w | ATP synthase subunit beta, mitochondrial | Oxidative phosphorylation | 0.2 | |
| PF14_0627 | 40S ribosomal protein S3 | Ribosome, translation | 5.5 | |
| PFC0735w MAL3P6.30 | 40S ribosomal protein S15A, putative | Ribosome, translation | 0.1 | |
| MAL7P1.130 | 3-demethylubiquinone-9 3-methyltransferase, putative | UPS | 3.4 | |
| MAL13P1.190 | 26S proteasome regulatory subunit RPN3, putative (RPN3) | UPS | 3.3 | |
| MAL3P4.5, PFC0550w | ubiquitin-protein ligase, putative (HRD3) | UPS | 0.4 | |
| PF11_0168, RON4 | rhoptry neck protein 4 (RON4) | Host cell invasion | 0.1 | |
| PF14_0558 | DN spindle assembly abnormal protein 4, putative (SAS4) A replication | DNA duplication | 5.3 | |
| PF10_0212, PF10_0212a | schizont egress antigen-1 (SEA1) | DNA duplication | 2.1 | |
| MAL5P1.146, PFE0730c | ribose 5-phosphate epimerase, putative | Coenzyme metabolic process | 4.1 | |
| 2277.t00420, MAL12P1.418, PFL2100w | ubiquitin-conjugating enzyme E2, putative | Acid-amino acid ligase | 0.2 | |
| 2277.t00392, MAL12P1.390, PFL1960w | proteasome regulatory protein, putative | UPS | 4 | |
| PF13_0063 | 26S protease regulatory subunit 7, putative (RPT1) | UPS | 0.4 | |
| 2277.t00420, MAL12P1.418, PFL2100w | ubiquitin-conjugating enzyme E2, putative | UPS | 0.2 | |
| - | E3 ubiquitin ligase | UPS | 3 | |
| - | 40S ubiquitin proteasome | UPS | 7 | |
| - | PfSEA1 | host cell membrane | 4 | |
| - | Transcription TFIID like | DNA-dependent transcription | 0.1 | |
| - | eIF2 | UPS | 42 |
Values above 1.0 represent up-regulated genes. (e.g., fold change = 5.0 means that the expression levels of these genes in treated parasites are 5 times higher compared to those in the controls), values below 1.0 represent down-regulated genes (e.g., fold change = 0.2 means that the expression levels pf these genes in treated parasites are 5 times lower compared to those in the controls).
Figure 6Melatonin and cAMP pathway modulation during the asexual cycle of P. falciparum development
The results in Table 2 were used to identify the pathways presented here.